Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
BCR-ABL1 Doubling-Times and Halving-Times May Predict CML Response to Tyrosine Kinase Inhibitors.
Pennisi MS, Stella S, Vitale SR, Puma A, Di Gregorio S, Romano C, Tirrò E, Massimino M, Antolino A, Siragusa S, Mannina D, Impera S, Musolino C, Mineo G, Martino B, Zammit V, Di Raimondo F, Manzella L, Stagno F, Vigneri P. Pennisi MS, et al. Among authors: puma a. Front Oncol. 2019 Aug 13;9:764. doi: 10.3389/fonc.2019.00764. eCollection 2019. Front Oncol. 2019. PMID: 31456947 Free PMC article.
Rapid decline of Philadelphia-positive metaphases after nilotinib treatment in a CML patient expressing a rare e14a3 BCR-ABL1 fusion transcript: A case report.
Massimino M, Stella S, Tirrò E, Consoli ML, Pennisi MS, Puma A, Vitale SR, Romano C, Zammit V, Stagno F, Di Raimondo F, Manzella L. Massimino M, et al. Among authors: puma a. Oncol Lett. 2019 Sep;18(3):2648-2653. doi: 10.3892/ol.2019.10558. Epub 2019 Jul 4. Oncol Lett. 2019. PMID: 31404304 Free PMC article.
ABL1-Directed Inhibitors for CML: Efficacy, Resistance and Future Perspectives.
Massimino M, Stella S, Tirrò E, Pennisi MS, Vitale SR, Puma A, Romano C, DI Gregorio S, Tomarchio C, DI Raimondo F, Manzella L. Massimino M, et al. Among authors: puma a. Anticancer Res. 2020 May;40(5):2457-2465. doi: 10.21873/anticanres.14215. Anticancer Res. 2020. PMID: 32366389 Review.
Prognostic and Therapeutic Roles of the Insulin Growth Factor System in Glioblastoma.
Tirrò E, Massimino M, Romano C, Martorana F, Pennisi MS, Stella S, Pavone G, Di Gregorio S, Puma A, Tomarchio C, Vitale SR, Manzella L, Vigneri P. Tirrò E, et al. Among authors: puma a. Front Oncol. 2021 Feb 2;10:612385. doi: 10.3389/fonc.2020.612385. eCollection 2020. Front Oncol. 2021. PMID: 33604294 Free PMC article. Review.
Impact of the Breakpoint Region on the Leukemogenic Potential and the TKI Responsiveness of Atypical BCR-ABL1 Transcripts.
Massimino M, Tirrò E, Stella S, Manzella L, Pennisi MS, Romano C, Vitale SR, Puma A, Tomarchio C, Di Gregorio S, Antolino A, Di Raimondo F, Vigneri P. Massimino M, et al. Among authors: puma a. Front Pharmacol. 2021 Jun 30;12:669469. doi: 10.3389/fphar.2021.669469. eCollection 2021. Front Pharmacol. 2021. PMID: 34276365 Free PMC article.
79 results